This event is archived. Final snapshot from when the story concluded. View on Dashboard
Events / Technology / Molecular Partners Presents MP0712...
Tech conference presentations

Molecular Partners Presents MP0712 at Conferences

Analysis based on 7 articles · First reported May 04, 2026 · Last updated May 04, 2026

Sentiment
20
Attention
2
Articles
7
Market Impact
General
Live prominence charts, article sentiment distribution, and event development timeline available on the Ergen Dashboard
Market Impact

The market may react positively to the increased visibility of Molecular Partners AG's lead candidate MP0712 through these presentations, potentially leading to a short-term increase in its stock price. The presentations could highlight the potential of DARPin therapeutics, attracting investor interest in the biotechnology sector.

Biotechnology Pharmaceuticals
Event Summary

Molecular Partners AG, a clinical-stage biotech company, announced its attendance and presentations at several upcoming scientific conferences in May 2026. The company will present on its lead Radio-DARPin candidate MP0712, a ²¹²Pb-based candidate for targeted anti-DLL3 radiotherapy of small cell lung cancer (SCLC). Presentations are scheduled for the NIH United States — National Cancer Institute 2026 Small Cell Lung Cancer Consortium Meeting, the 22nd Annual PEGS Boston, and Antibody & Engineering Therapeutics. These presentations aim to share molecular characteristics, preclinical insights, clinical development progress, and first-in-human insights for MP0712 and future DARPin candidates.

Entities Involved
per
Seth Lewis
Seth Lewis is the EVP Corporate Finance for Molecular Partners AG and is listed as a contact for further details regarding the company's presentations.
Importance 10.0 Sentiment 0.0
per
Laura Jeanbart
Laura Jeanbart is the Head of Portfolio Management & Communications for Molecular Partners AG and is listed as a contact for further details regarding the company's presentations.
Importance 10.0 Sentiment 0.0
govactor
United States — National Cancer Institute
Importance 0.0 Sentiment 0.0
priv
Orano
Importance 0.0 Sentiment 0.0
stock
Molecular Partners
Importance 0.0 Sentiment 0.0
ERGEN INTELLIGENCE
Track this event live

Set up alerts, explore entity relationships, search across thousands of events, and build custom intelligence feeds.

Open Dashboard

About Ergen

Ergen is a news intelligence platform that converts raw news articles into structured data. It tracks events, entities, and the relationships between them, with sentiment and attention metrics derived from thousands of articles. Pages on this site are daily static snapshots from the platform's live database. For real-time tracking, search, and alerts, the full dashboard is at app.ergen.ai.